A Study of B-701 in Combination With Pembrolizumab in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma
Clinical trial NCT03123055 · TERMINATED
Trial details
- NCT number
- NCT03123055
- Sponsor
- Rainier Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-20
- Primary completion
- 2019-12-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.